Role of exogenous surfactant in acute lung injury

Critical Care Medicine

Volumn 31, Issue 4 SUPPL., 2003, Pages

  Lewis, James F ^a   Brackenbury, Angela ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Acute respiratory distress syndrome; Clinical trials; Lung injury; Surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BLES; DIPALMITOYLPHOSPHATIDYLCHOLINE; HL 10; LUCINACTANT; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; LUSUPULTIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE SEVERITY; HOST RESISTANCE; HUMAN; LUNG INJURY; MEDLINE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; TREATMENT OUTCOME;

EID: 0037391328     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000057911.19145.9f     Document Type: Conference Paper

References (27)

1. Veldhuizen R, Nag K, Orgeig S, et al: The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1998; 1408:90-108
2. Weaver TE, Conkright JJ: Functions of surfactant proteins B and C. Annu Rev Physiol 2001; 63:555-578
3. Wright JR, Dobbs LG: Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 1991; 53;395-414
4. Brackenbury AM, Malloy JL, McCaig LA, et al: Evaluation of alveolar surfactant aggregates in vitro and in vivo. Eur Respir J 2002; 19:41-46
5. Veldhuizen RA, Yao LJ, Lewis JF: An examination of the different variables affecting surfactant aggregate conversion in vitro. Exp Lung Res 1999; 25:127-141
6. Lewis JF, Jobe AH: Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147:218-233
7. McCormack FX, Whitsett JA: The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109:707-712
8. LeVine AM, Whitsett JA, Gwozdz JA, et al: Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165;3934-3940
9. LeVine AM, Whitsett JA, Hartshorn KL: Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001; 167:5868-5873
10. De Sanctis GT, Tomkiewicz RP, Rubin BK, et al: Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog. Eur Respir J 1994; 7:1616-1621
11. Ashbaugh DG, Bigelow DB, Petty TL, et al: Acute respiratory distress in adults. Lancet 1967; 12:319-323
12. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
13. Veldhuizen RA, McCaig LA, Akino T, et al: Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152:1867-1871
14. Lewis JF, Veldhuizen R, Possmayer F, et al: Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep. Am J Respir Crit Care Med 1994; 150:123-130
15. Hallman M, Spragg R, Harrell JH, et al: Evidence of lung surfactant abnormality in respiratory failure: Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982; 70:673-683
16. Doyle IR, Bersten AD, Nicholas TE: Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 1997; 156:1217-1229
17. Zhu S, Ware LB, Geiser T, et al: Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001; 163:166-172
18. Ito Y, Veldhuizen RA, Yao LJ, et al: Ventilation strategies affect surfactant aggregate conversion in acute lung injury. Am J Respir Crit Care Med 1997; 155:493-499
19. Kobayashi T, Nitta K, Ganzuka M, et al: Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991; 29:353-356
20. Anzueto A, Baughman RP, Guntupalli KK, et al: Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome: Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996; 334:1417-1421
21. Gregory TJ, Steinberg KP, Spragg R, et al: Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:1309-1315
22. Spragg R, Harris KW, Lewis J, et al: Surfactant treatment of patients with ARDS may reduce acute lung inflammation. Am J Respir Crit Care Med 2001; 163:A23
23. Lewis JF, Goffin J, Yue P, et al: Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury. J Appl Physiol 1996; 80:1156-1164
24. Hafner D, Germann PG, Hauschke D: Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury. Am J Respir Crit Care Med 1998; 158:270-278
25. Ito Y, Manwell SE, Kerr CL, et al: Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. Am J Respir Crit Care Med 1998; 157:149-155
26. Malloy JL, Veldhuizen RA, McCormack FX, et al: Pulmonary surfactant and inflammation in septic adult mice: Role of surfactant protein A. J Appl Physiol 2002; 92:809-816
27. Bailey TC, Cavanagh C, Mehta S, et al: Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knock-out mice. Eur Respir J 2002; 20:177-182